Showing results (31-40 of 532) with videos related to
Sort By:
Pageof 54
Circulation|December 24, 2003
Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currentsBenoit Drolet, Chantale Simard, Dan M RodenCardiovascular Research|January 21, 2004
Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoterPing Yang, Sabina Kupershmidt, Dan M RodenCirculation|July 2, 2003
Phosphorylation of the IKs channel complex inhibits drug block: novel mechanism underlying variable antiarrhythmic drug actionsTao Yang, Hideaki Kanki, Dan M RodenEuropace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 9, 2007
A memorable experienceKen Monahan, Walter Clair, Dan M RodenCirculation|February 19, 2017
Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot StudyDavid G Strauss, Jose Vicente, Lars Johannesen, et al.Heart Rhythm|January 25, 2019
Multiple mechanisms underlie increased cardiac late sodium currentBrett M Kroncke, Tao Yang, Dan M RodenCurrent Pharmaceutical Design|November 21, 2009
Arrhythmia pharmacogenomics: methodological considerationsDan M Roden, Prince J Kannankeri, Dawood DarbarNature Communications|June 7, 2022
The 3D mutational constraint on amino acid sites in the human proteomeBian Li, Dan M Roden, John A CapraAnnual Review of Genomics and Human Genetics|May 6, 2016
Phenome-Wide Association Studies as a Tool to Advance Precision MedicineJoshua C Denny, Lisa Bastarache, Dan M RodenThe Journal of Clinical Investigation|July 19, 2005
Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistanceBenoit Drolet, Chantale Simard, Laura Mizoue, et al.Pageof 54